Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.430
+0.280 (13.02%)
At close: Jun 6, 2025, 4:00 PM
2.420
-0.010 (-0.41%)
After-hours: Jun 6, 2025, 7:54 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $75.29 million as of June 6, 2025. Its market cap has decreased by -77.64% in one year.
Market Cap
75.29M
Enterprise Value
16.48M
1-Year Change
-77.64%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $75.29M, a decrease of -78.86%. That is a compound annual growth rate of -74.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 66.60M | -22.47% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.02B |
| Johnson & Johnson | 369.40B |
| AbbVie | 331.20B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.14B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |